Clinical OMICS

MAR-APR 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/1093879

Contents of this Issue

Navigation

Page 0 of 51

JANUARY/FEBRUARY 2018 VOL. 5, ISSUE NO. 1 VOL. 6, ISSUE NO. 2 MARCH/APRIL 2019 MAY 29, 2014 ISSUE No. 4 A digital publication of GEN, a Mary Ann Liebert, Inc. company Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Innovative Practices, Actionable Results JULY/AUGUST 2017 VOL. 4, ISSUE No. 4 Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Molecular Diagnostics in Personalized Medicine ISSUE NO. 1 JANUARY/FEBRUARY 2019 England's NHS Rolls Out Countrywide Genomic Medicine Service Epigenetics Inches the Clinic Challenges of CDx Development Sinai's Precision Push Translating OMICs into Cancer Biology and Medicine Payers Wrestle with Reimbursement Best New Clinical Apps Innovator: Lawrence Brody New Products & More APRIL 23, 2014 No. 1 Innovative Practices, Actionable Results Researchers Turn to the Cloud as Genomic Data Explodes Advanced Genomic Methods Battle Against Microbial Resistance Coalition Seeks Broader Adoption of NIPT Health Systems Combine EHR and Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup FEBRUARY 2015 VOL. 2, ISSUE No. 2 Molecular Diagnostics in Personalized Medicine Nanopore Nanopore Sequencing: Sequencing: The New Front Line of The New Front Line of Infectious Disease Diagnostics Infectious Disease Diagnostics Point-of-Care Molecular Point-of-Care Molecular Diagnostics Evolve Diagnostics Evolve CASE STUDY: CASE STUDY: Taking Control of Taking Control of Operational Genomics Operational Genomics JULY VOL. 2, ISSUE No. 7 Molecular Diagnostics in Personalized Medicine A Larger Role for Genomics in Immuno-Oncology Liquid Biopsy Gets Ready for Prime Time A digital publication of GEN, a Mary Ann Liebert, Inc. company VOL. 5, ISSUE NO. 6 NOVEMBER/DECEMBER DECEMBER 10, 2014 SEPTEMBER/OCTOBER VOL. 4, ISSUE No. 5 CRISPR CRISPR Competition Competition Heats Heats Of Biomarkers Of Biomarkers and and Machine Learning Machine Learning Hijacking Hijacking Computers Computers with with Honing Prenatal Screening Tests Near or Far? Omics Data Management, Analysis, and Action Smartphone Based Biosensors —Just What the mDiagnostician Ordered Events Roundup, New Products & More SEPTEMBER 10, ISSUE No. 9 Innovative Practices, Actionable Results ISSUE No. 15 Molecular Diagnostics in Personalized Medicine Smartphone Based Biosensors —Just What the mDiagnostician Ordered Meeting Roundup, New Products & More A digital publication of GEN, a Mary Ann Liebert, Inc. company Best New Clinical Apps Innovator: Lawrence Brody New Products & More Unlocking Unlocking the Microbiome the Microbiome GTEx Links Variants GTEx Links Variants to Expression to Expression A digital publication of GEN, a Mary Ann Liebert, Inc. company POC Testing Revs Up POC Testing Revs Up Speeds Forward Speeds Forward Kingsmore Kingsmore Stephen Stephen VOL. 4, ISSUE No. 6 NOVEMBER/DECEMBER 2017 with Reimbursement Payers Wrestle and Medicine into Cancer Biology Translating OMICs Analysis, and Action Omics Data Management, Near or Far? Screening Tests Honing Prenatal A digital publication of GEN, a Mary Ann Liebert, Inc. company Innovative Practices, Actionable Results ISSUE No. 3 MAY 15, 2014 New Products & More Innovator: Leroy Hood Best Clinical Apps to Vexing Variants Interpretation Bringing Informed with Bioinformatics Anticipating "Panomics" Future Cancer Care New Products & More Innovator: Leroy Hood Best Clinical Apps to Vexing Variants Interpretation Bringing Informed with Bioinformatics Anticipating "Panomics" Future Cancer Care VOL. 3, ISSUE No. 10 NOVEMBER/DECEMBER 2016 Molecular Diagnostics in Personalized Medicine Picks Up Steam ASCO's CancerLinQ Partner for Cancer Care MD Anderson, Scripps Health from FDA on LDTs Industry Awaits Word Disease Less Rare Sequencing Makes Commonplace Picks Up Steam ASCO's CancerLinQ Partner for Cancer Care MD Anderson, Scripps Health from FDA on LDTs Industry Awaits Word Disease Less Rare Sequencing Makes Commonplace A digital publication of GEN, a Mary Ann Liebert, Inc. company New Products & More Meeting Roundup for Cancer Testing The National Access Project Balancing Cost and Value Genomic Medicine: Diagnostics for Cancer Noninvasive Molecular New Products & More New Products & More Meeting Roundup Meeting Roundup for Cancer Testing The National Access Project for Cancer Testing The National Access Project Balancing Cost and Value Balancing Cost and Value Genomic Medicine: Genomic Medicine: Diagnostics for Cancer Diagnostics for Cancer Noninvasive Molecular Noninvasive Molecular VOL. 4, ISSUE No. 2 MARCH/APRIL 2017 Molecular Diagnostics in Personalized Medicine Ready for Prime Time Liquid Biopsy Gets Immuno-Oncology for Genomics in A Larger Role Meeting Roundup Functional Serum Biomarkers Case Study: Discovery of on Clinical Lab Billing Uncle Sam Casts Wary Eye Beyond the Sequence VOL. 4, ISSUE No. 1 JANUARY/FEBRUARY 2017 Molecular Diagnostics in Personalized Medicine Combine EHR and Health Systems Adoption of NIPT Coalition Seeks Broader Microbial Resistance Methods Battle Against Advanced Genomic Genomic Data Explodes Turn to the Cloud as Researchers Cancer Care Community for 2019 Experts Predictions of Metabolomics The Complexity Provide Valuable Circulating Tumor Liquid Logic Fibrillation Beat in Atrial Keeping the Questions More CRISPR from Wearables New Biomarkers Genomes Club 100,000 SEPTEMBER/OCTOBER 2018 ISSUE NO. 5 ANNIVERSARY ISSUE th

Articles in this issue

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2019